Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$668M |
| 2 |
Chevron
CVX
|
+$626M |
| 3 |
NVIDIA
NVDA
|
+$567M |
| 4 |
Microsoft
MSFT
|
+$538M |
| 5 |
CRH
CRH
|
+$534M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$599M |
| 2 |
Intel
INTC
|
+$509M |
| 3 |
Eli Lilly
LLY
|
+$240M |
| 4 |
Analog Devices
ADI
|
+$239M |
| 5 |
EOG Resources
EOG
|
+$203M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.61% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Financials | 10.25% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONT
1551
Onterris Inc
ONT
$710M
| $158K | ﹤0.01% |
6,321
+289
| +5% | +$11K |
|
1552
Pathward Financial
CASH
$1.81B
| $158K | ﹤0.01% |
3,335
-169
| -5% | -$8.41K |
|
1553
Antero Midstream
AM
$10.8B
| $157K | ﹤0.01% |
+12,600
| New | +$149K |
|
1554
DNOW Inc
DNOW
$2.63B
| $156K | ﹤0.01% |
13,253
-783
| -6% | -$8.74K |
|
1555
First Commonwealth Financial
FCF
$2.12B
| $156K | ﹤0.01% |
12,813
| – | – |
|
1556
Sotera Health
SHC
$4.95B
| $156K | ﹤0.01% |
11,642
| – | – |
|
1557
Trupanion
TRUP
$1.05B
| $155K | ﹤0.01% |
6,107
| – | – |
|
1558
Matthews International
MATW
$864M
| $154K | ﹤0.01% |
3,968
-109
| -3% | -$4.72K |
|
1559
ProKidney
PROK
$308M
| $154K | ﹤0.01% |
55,502
+13,125
| +31% | +$126K |
|
1560
Myriad Genetics
MYGN
$530M
| $152K | ﹤0.01% |
10,443
-15
| -0.1% | -$285 |
|
1561
AZZ Inc
AZZ
$4.5B
| $150K | ﹤0.01% |
3,191
-5
| -0.2% | -$229 |
|
1562
Cushman & Wakefield Ltd
CWK
$2.98B
| $150K | ﹤0.01% |
20,380
-854
| -4% | -$7.73K |
|
1563
Ubiquiti
UI
$31.8B
| $149K | ﹤0.01% |
1,290
| – | – |
|
1564
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1.02B
| $149K | ﹤0.01% |
6,700
-9,300
| -58% | -$200K |
|
1565
Progyny
PGNY
$2.44B
| $149K | ﹤0.01% |
4,503
| – | – |
|
1566
Caleres
CAL
$396M
| $149K | ﹤0.01% |
5,518
-311
| -5% | -$8.25K |
|
1567
Kaiser Aluminum
KALU
$2.67B
| $148K | ﹤0.01% |
2,208
+10
| +0.5% | +$759 |
|
1568
SPDR Gold Trust
GLD
$131B
| $148K | ﹤0.01% |
825
-900
| -52% | -$161K |
|
1569
Artisan Partners
APAM
$2.79B
| $146K | ﹤0.01% |
4,100
-3,400
| -45% | -$132K |
|
1570
United Natural Foods
UNFI
$3.01B
| $145K | ﹤0.01% |
9,430
| – | – |
|
1571
National Bank Holdings
NBHC
$1.93B
| $143K | ﹤0.01% |
4,782
| – | – |
|
1572
Allegiant Air
ALGT
$2.64B
| $143K | ﹤0.01% |
1,959
| – | – |
|
1573
Stewart Information Services
STC
$2.05B
| $142K | ﹤0.01% |
3,414
| – | – |
|
1574
Core Laboratories
CLB
$538M
| $141K | ﹤0.01% |
5,903
| – | – |
|
|
ACH
1575
Accendra Health
ACH
$240M
| $141K | ﹤0.01% |
9,538
-423
| -4% | -$7.51K |
|
Similar funds
Amundi's Q3 2023 Portfolio in Review
As of Q3 2023, Amundi held 2,094 positions worth $203B, up 2.9% from $198B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Amundi deployed $11.1B of net new capital in Q3 2023, opening 69 new positions and adding to 881 existing holdings. Its largest new stake was Kenvue: 14,174,156 shares worth $275M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $599M trimmed.
- Amundi's largest Q3 2023 buy was Kenvue: 14,174,156 shares worth $275M.
- Amundi added most to UnitedHealth in Q3 2023, an estimated $668M increase.
- Amundi's biggest Q3 2023 reduction was Advanced Micro Devices, cutting an estimated $599M.
- Amundi fully exited Elanco Animal Health in Q3 2023, selling an estimated $25.3M.
- Amundi's ten largest holdings make up 23% of its $203B portfolio in Q3 2023.
- Amundi opened 69 new positions and closed 87 in Q3 2023.
- Amundi's portfolio value rose 2.9% quarter-over-quarter to $203B.
Based on Amundi's 13F filing for Q3 2023, filed 14 Nov 2023.